The growing interest in US psilocybin microdose capsules reflects an evolution in treatment paradigms.
What is considered a dose of psilocybin?
A typical microdose ranges from 0.1 mg to 0.3 mg of pure psilocybin, well under the normal dose of psilocybin used in clinical trials.
Psilocybin therapy in US
Current investigations suggest the potential of psilocybin microdoses in treating depression, with thousands treated with psilocybin reporting improved mood.
Regulatory landscape
Is psilocybin a scheduled drug? Regulations differ, including Maryland and select regions moving toward medical legalization.
- Potential side effects are typically low, including temporary anxiety.
- Peer reviewed articles on psilocybin highlight differences across mushroom types.
- International studies offer additional insight on clinical benefits.
The latest news side effects of microdosing psilocybin on psilocybin research reinforce that microdosing protocols is becoming mainstream across America.